Publisher
source

Avi Schroeder

9 months ago

PhD Position: RNA Interference-Based Lipid Nanoparticles for Solid Tumour Treatment University of Udine in Italy

Degree Level

PhD

Field of study

Biochemistry

Funding

Full funding available

Deadline

Expired

Country flag

Country

Italy

University

University of Udine

Social connections

How do I apply for this?

Sign in for free to reveal details, requirements, and source links.

Suggested positions

Keywords

Biochemistry
Chemistry
Biomedical Engineering
Chemical Engineering
Materials Science
Drug Delivery
Biotechnology
Organic Chemistry
Health Science
Personalized Medicine
Nanoscience
Rna Interference
Lipid Chemistry
Gene Silencing
Nanomedicine
Cancer Therapy
In Vivo Testing
Brain Tumor
Solid Tumor

About this position

This PhD project focuses on the development of RNA interference (RNAi)-based lipid nanoparticles (LNPs) as advanced therapeutic vehicles for the treatment of solid tumours. The research will center on the chemical design and optimization of lipid components to achieve efficient RNA encapsulation, stability, and targeted delivery to cancer cells.

Special attention will be given to tailoring lipid composition and integrating targeting strategies that promote selective uptake by tumour cells while minimizing off-target effects. The project will involve evaluating the formulations for their ability to penetrate tumour tissue and induce gene silencing in cancer cell models, followed by in vivo studies to assess biodistribution, tumour accumulation, and therapeutic efficacy. The ultimate goal is to establish a robust nanoparticle platform that combines efficient RNA encapsulation, tumour-targeted delivery, and significant therapeutic activity, paving the way for clinical translation of RNAi-based nanomedicines in oncology. The host institution is the Technion Research and Development Foundation in Haifa, Israel, with research conducted in the Louis Family Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies, led by Prof.

Avi Schroeder. The laboratory specializes in innovative medical technologies, particularly targeted drug delivery systems for cancer and neurodegenerative diseases, and offers a multinational, multidisciplinary research environment. The project includes strong collaborations and secondments with Prof. Rory Johnson at University College Dublin, Ireland, and Roy Nevo at Mana Bio Ltd., Israel, requiring a willingness to travel and spend time abroad.

Applicants must have a Master’s degree in Organic Chemistry, Chemical Engineering, Biotechnology, Biochemistry, or related fields, and must not already possess a doctoral degree. Research experience in organic chemistry and biochemical techniques is required, with additional experience in chemical synthesis and nanoparticle formulation considered advantageous. Proficiency in English is mandatory, with proof required unless exempted.

The position is funded through a doctoral fellowship, including stipend and support for travel and secondments. The application deadline is January 31, 2026. For more information and to apply, visit the INT2ACT recruitment web page.

Funding details

Full funding including tuition fees and living expenses is available for this position. The scholarship covers all educational costs and provides a monthly stipend.

Ask ApplyKite AI

Start chatting
Can you summarize this position?
What qualifications are required for this position?
How should I prepare my application?

Professors